Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Pharmacogenomics is an essential research area for development of medication for pain, cancer, psychotropic, and cardiovascular disease. The success of this medication is possible through the use of innovative technologies that help define the dosage setting for subsets of the population and an individual’s response to a specific drug. The success of the precision medicine is possible through the application of pharmacogenomics that uses information about a person’s genes, enzyme activities, cellular environment, and proteins to diagnose and treat diseases. Rapid advancements in groups of specialized molecular diagnostic tests is contributing to the improvement for assessment of real-time treatment of diseases.
Market Dynamics
Major factors that propel the market are increasing demand for personalized drugs, increasing prevalence of several non-infectious and infectious diseases, rising utilization of these technology for effective treatment therapeutics, and growing awareness about benefits associated with pharmacogenomics. Continuous collaboration among pharmacogenomics manufacturers for various applications in clinical and translational research is also expected to drive growth of the market across regions. In 2016, Merck & Co. Inc., collaborated with Biocartis, an innovative molecular diagnostic company to develop and commercialize a new liquid biopsy technology for RAS biomarker testing. This can enable more access to the test for number of metastatic colorectal cancer patients. Furthermore, use of pharmacogenomics to perform diagnostic assays in the field of determining individual’s susceptibility to certain diseases, toxicology, biochemical genetics, and drug safety are also expected to lead to rapid growth of the market for pharmacogenomics over the forecast period.
Key features of the study:
This report provides in-depth analysis of pharmacogenomics and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017 – 2025), considering 2016 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, regulatory scenario, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global pharmacogenomics market based on the following parameters – company overview, financial performance, geographical presence, key developments and strategies, and future plans
Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Bayer AG, AstraZeneca plc, Assurex Health, GE Healthcare, Bristol-Myers Squibb Company, Qiagen, Inc., F. Hoffmann-La Roche Ltd, Transgenomic, Inc., Abbott Laboratories, Inc., and GlaxoSmithKline
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future type up-gradation, market expansion, and marketing tactics
The global pharmacogenomics market report caters to various stakeholders in this industry including investors, researchers, pharmacogenomics manufacturers, new entrants, and financial analysts.
Stakeholders would have ease in decision making through the various strategy matrices used in analyzing the pharmacogenomics market.
Detailed Segmentation:
Global Pharmacogenomics Market, By Technology Type:
Polymerase Chain Reaction
Sequencing
Microarray
Other Technologies
Global Pharmacogenomics Market, By Application:
Drug Discovery
Therapeutic Application
Oncology
Cardiology
Pain Management
Neurological Disorders
Others
Global Pharmacogenomics Market, By Geography:
North America
By Country:
U.S.
Canada
By Technology Type:
Polymerase Chain Reaction
Sequencing
Microarray
Other Technologies
By Application:
Drug Discovery
Therapeutic Application
Oncology
Cardiology
Pain Management
Neurological Disorders
Others
Europe
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
By Technology Type:
Polymerase Chain Reaction
Sequencing
Microarray
Other Technologies
By Application:
Drug Discovery
Therapeutic Application
Oncology
Cardiology
Pain Management
Neurological Disorders
Others
Asia Pacific
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
By Technology Type:
Polymerase Chain Reaction
Sequencing
Microarray
Other Technologies
By Application:
Drug Discovery
Therapeutic Application
Oncology
Cardiology
Pain Management
Neurological Disorders
Others
Latin America
By Country:
Brazil
Mexico
Rest of Latin America
By Technology Type:
Polymerase Chain Reaction
Sequencing
Microarray
Other Technologies
By Application:
Drug Discovery
Therapeutic Application
Oncology
Cardiology
Pain Management
Neurological Disorders
Others
Middle East
By Country:
GCC
Israel
Rest of Middle East
By Technology Type:
Polymerase Chain Reaction
Sequencing
Microarray
Other Technologies
By Application:
Drug Discovery
Therapeutic Application
Oncology
Cardiology
Pain Management
Neurological Disorders
Others
Africa
By Country:
North Africa
Central Africa
South Africa
By Technology Type:
Polymerase Chain Reaction
Sequencing
Microarray
Other Technologies
By Application:
Drug Discovery
Therapeutic Application
Oncology
Cardiology
Pain Management
Neurological Disorders
Others
Company Profiles
Thermo Fisher Scientific Inc.*
Company Overview
Technology Portfolio
Financial Performance
Key Strategies
Recent Developments
Future Plans
Bayer AG
AstraZeneca plc
Assurex Health
GE Healthcare
Bristol-Myers Squibb Company
Qiagen, Inc.
Hoffmann-La Roche Ltd
Transgenomic, Inc.
Abbott Laboratories, Inc.
GlaxoSmithKline
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Overview
o Report Description
o Market Definition and Scope
o Executive Summary
o Market Snippet, By Technology Type
o Market Snippet, By Application
o Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Drivers
o Supply Side Drivers
o Demand Side Drivers
o Economic Drivers
o Restraints
o Market Opportunities
o Impact Analysis
o Epidemiology
o Regulatory Scenario
o Industry Trends
o PEST Analysis
4. Global Pharmacogenomics Market, By Technology Type, 2017 - 2025, (US$ Million)
o Introduction
o Market Share Analysis, 2016 and 2025 (%)
o Y-o-Y Growth Analysis, 2017 - 2025
o Segment Trends
o Polymerase Chain Reaction
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Sequencing
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Microarray
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Other Technologies
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
5. Global Pharmacogenomics Market, By Application, 2017 - 2025, (US$ Million)
o Introduction
o Market Share Analysis, 2016 and 2025 (%)
o Y-o-Y Growth Analysis, 2017 - 2025
o Segment Trends
o Drug Discovery
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Therapeutic Application
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
• Oncology
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
• Cardiology
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
• Pain Management
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
• Neurological Disorders
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
• Others
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
6. Global Pharmacogenomics Market, By Regions, 2017 - 2025, (US$ Million)
o Introduction
o Market Share Analysis, By Region, 2016 and 2025 (%)
o Y-o-Y Growth Analysis, By Regions, 2017 - 2025
o North America
o Market Size and Forecast, By Technology, 2017 - 2025, (US$ Million)
o Market Size and Forecast, By Application, 2017 - 2025, (US$ Million)
o Market Size and Forecast, By Country, 2017 - 2025, (US$ Million)
o U.S.
o Canada
o Europe
o Market Size and Forecast, By Technology, 2017 - 2025, (US$ Million)
o Market Size and Forecast, By Application, 2017 - 2025, (US$ Million)
o Market Size and Forecast, By Country, 2017 - 2025, (US$ Million)
o U.K.
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
o Market Size and Forecast, By Technology, 2017 - 2025, (US$ Million)
o Market Size and Forecast, By Application, 2017 - 2025, (US$ Million)
o Market Size and Forecast, By Country, 2017 - 2025, (US$ Million)
o China
o Japan
o India
o ASEAN
o Australia
o South Korea
o Rest of Asia Pacific
o Latin America
o Market Size and Forecast, By Technology, 2017 - 2025, (US$ Million)
o Market Size and Forecast, By Application, 2017 - 2025, (US$ Million)
o Market Size and Forecast, By Country, 2017 - 2025, (US$ Million)
o Brazil
o Mexico
o Rest of Latin America
o Africa
o Market Size and Forecast, By Technology, 2017 - 2025, (US$ Million)
o Market Size and Forecast, By Application, 2017 - 2025, (US$ Million)
o Market Size and Forecast, By Country, 2017 - 2025, (US$ Million)
o Northern Africa
o Central Africa
o South Africa
o Middle East
o Market Size and Forecast, By Technology, 2017 - 2025, (US$ Million)
o Market Size and Forecast, By Application, 2017 - 2025, (US$ Million)
o Market Size and Forecast, By Country, 2017 - 2025, (US$ Million)
o GCC Countries
o Israel
o Rest of Middle East
7. Competitive Landscape
o Heat Map Analysis
o Market Share Analysis
o Company Profiles
o Bayer AG
o Company Overview
o Technology Portfolio
o Financial Performance
o Recent Developments/Updates
o Future Plans
o Thermo Fisher Scientific Inc.
o Company Overview
o Technology Portfolio
o Financial Performance
o Recent Developments/Updates
o Future Plans
o AstraZeneca plc
o Company Overview
o Technology Portfolio
o Financial Performance
o Recent Developments/Updates
o Future Plans
o Assurex Health
o Company Overview
o Technology Portfolio
o Financial Performance
o Recent Developments/Updates
o Future Plans
o GE Healthcare
o Company Overview
o Technology Portfolio
o Financial Performance
o Recent Developments/Updates
o Future Plans
o Bristol-Myers Squibb Company
o Company Overview
o Technology Portfolio
o Financial Performance
o Recent Developments/Updates
o Future Plans
o Qiagen, Inc.
o Company Overview
o Technology Portfolio
o Financial Performance
o Recent Developments/Updates
o Future Plans
o F. Hoffmann-La Roche Ltd
o Company Overview
o Technology Portfolio
o Financial Performance
o Recent Developments/Updates
o Future Plans
o Transgenomic, Inc.
o Company Overview
o Technology Portfolio
o Financial Performance
o Recent Developments/Updates
o Future Plans
o Abbott Laboratories, Inc.
o Company Overview
o Technology Portfolio
o Financial Performance
o Recent Developments/Updates
o Future Plans
o GlaxoSmithKline
o Company Overview
o Technology Portfolio
o Financial Performance
o Recent Developments/Updates
o Future Plans
8. Section
o References
o Analyst Views
o Research Methodology
o About Us and Sales Contact
*Browse 29 market data tables and 33 figures on "Pharmacogenomics Market - Global forecast to 2025".
